Pharmaceutical Quality Submissions to Food & Drug Administration (PQ/CMC), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.1.20 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition
Resource MedicinalProductDefinition "89676a69-1fe7-422c-ab00-92abe4ef6ea9"
Profile: Routine Drug Product
identifier: Example2BeadDrug
combinedPharmaceuticalDoseForm: CAPSULE (Dummy NCIT Codesystem#C25158)
route: ORAL (Dummy NCIT Codesystem#C38288)
name
productName: OXAZEPAM 30mg, PROPRANOLOL HYDROCHLORIDE 60mg
type: Non-Proprietary (Product Name Types Code Types#NON)
part
part: OXAZEPAM
type: scientific name (EntityNamePartQualifierR2#SCI)
part
part: 30mg
type: strength name (EntityNamePartQualifierR2#STR)
part
part: PROPRANOLOL HYDROCHLORIDE
type: scientific name (EntityNamePartQualifierR2#SCI)
part
part: 60mg
type: strength name (EntityNamePartQualifierR2#STR)